{"ticker": "ALVR", "overview": {"cik": "1754068", "ticker": "KLRS", "name": "Kalaris Therapeutics, Inc.", "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "sic": "2836", "announcements": [{"form": "4", "date": "2026-08-28", "title": "Insider transaction", "accession": "0001193125-26-374352", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-11", "title": "Quarterly report", "accession": "0001193125-26-344532", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-11", "title": "Material event", "accession": "0001193125-26-343477", "price_sensitive": true}, {"form": "4", "date": "2026-08-03", "title": "Insider transaction", "accession": "0001193125-26-330530", "price_sensitive": false}, {"form": "3", "date": "2026-08-03", "title": "Initial insider holdings", "accession": "0001193125-26-330516", "price_sensitive": false}, {"form": "3", "date": "2026-07-27", "title": "Initial insider holdings", "accession": "0001193125-26-318054", "price_sensitive": false}, {"form": "4", "date": "2026-07-20", "title": "Insider transaction", "accession": "0001193125-26-309047", "price_sensitive": false}, {"form": "3", "date": "2026-07-20", "title": "Initial insider holdings", "accession": "0001193125-26-309027", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-20", "title": "Material event", "accession": "0001193125-26-308382", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-17", "title": "Material event", "accession": "0001193125-26-306737", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-06", "title": "Material event", "accession": "0001193125-26-296190", "price_sensitive": true}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257564", "price_sensitive": false}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257556", "price_sensitive": false}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257494", "price_sensitive": false}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257471", "price_sensitive": false}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257465", "price_sensitive": false}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257462", "price_sensitive": false}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257445", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-04", "title": "Material event", "accession": "0001193125-26-257388", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2026-05-22", "title": "Form SCHEDULE 13D/A", "accession": "0001699737-26-000012", "price_sensitive": false}, {"form": "4", "date": "2026-05-22", "title": "Insider transaction", "accession": "0001231919-26-000532", "price_sensitive": false}, {"form": "10-Q", "date": "2026-05-12", "title": "Quarterly report", "accession": "0001193125-26-219328", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-12", "title": "Material event", "accession": "0001193125-26-218240", "price_sensitive": true}, {"form": "ARS", "date": "2026-04-24", "title": "Form ARS", "accession": "0001193125-26-177387", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-04-24", "title": "Form DEFA14A", "accession": "0001193125-26-177383", "price_sensitive": false}]}, "description": "ALVR trades as ALVR. Privy Trades holds 289 insider filings for the company, from August 2020 to February 2025. Across those, 15 insiders disclosed 7 open-market purchases totalling $60.58M against 188 sales totalling $46.41M. The most recent filing on record is dated 21 February 2025.", "exchange": null, "stats": {"buy_n": 7, "buy_sum": 60575909.0, "sell_n": 188, "sell_sum": 46408988.249325, "net": 14166920.750675, "insiders": 15, "first_date": "2020-08-03", "last_date": "2025-02-21"}, "metrics": {"ticker": "ALVR", "has_prices": false}, "trades": [{"id": "0000950170-25-025630", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Edward Miller", "who_key": "Miller Edward", "role": "General Counsel", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 1068.0348, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider offloads $1K of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017025025630/0000950170-25-025630-index.htm", "trade_date": "2025-02-21", "timestamp": "2025-02-21", "mins": 892241}, {"id": "0000950170-25-025633", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Brett R. Hagen", "who_key": "Hagen Brett R", "role": "Chief Accounting Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 967.2767999999999, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "An exit at the top? Exec sells $967 of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017025025633/0000950170-25-025633-index.htm", "trade_date": "2025-02-21", "timestamp": "2025-02-21", "mins": 892241}, {"id": "0000950170-25-025634", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Vikas Sinha", "who_key": "Sinha Vikas", "role": "See Remarks, Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 3052.9673999999995, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director sells $3K of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017025025634/0000950170-25-025634-index.htm", "trade_date": "2025-02-21", "timestamp": "2025-02-21", "mins": 892241}, {"id": "0000950170-25-009197", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Vikas Sinha", "who_key": "Sinha Vikas", "role": "See Remarks, Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 1225.8634, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Boardroom sells $1K of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017025009197/0000950170-25-009197-index.htm", "trade_date": "2025-01-23", "timestamp": "2025-01-23", "mins": 934001}, {"id": "0000950170-25-009204", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Brett R. Hagen", "who_key": "Hagen Brett R", "role": "Chief Accounting Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 342.2824, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "An exit at the top? Exec sells $342 of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017025009204/0000950170-25-009204-index.htm", "trade_date": "2025-01-23", "timestamp": "2025-01-23", "mins": 934001}, {"id": "0000950170-25-009205", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Edward Miller", "who_key": "Miller Edward", "role": "General Counsel", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 494.0296, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider sells $494 of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017025009205/0000950170-25-009205-index.htm", "trade_date": "2025-01-23", "timestamp": "2025-01-23", "mins": 934001}, {"id": "0000950170-25-004832", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Vikas Sinha", "who_key": "Sinha Vikas", "role": "See Remarks, Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 430.8579, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "A director trims ALVR: $430", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017025004832/0000950170-25-004832-index.htm", "trade_date": "2025-01-10", "timestamp": "2025-01-10", "mins": 952721}, {"id": "0000950170-25-004833", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Brett R. Hagen", "who_key": "Hagen Brett R", "role": "Chief Accounting Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 146.1132, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "An exit at the top? Exec sells $146 of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017025004833/0000950170-25-004833-index.htm", "trade_date": "2025-01-10", "timestamp": "2025-01-10", "mins": 952721}, {"id": "0000950170-25-004834", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Edward Miller", "who_key": "Miller Edward", "role": "General Counsel", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 180.0009, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider offloads $180 of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017025004834/0000950170-25-004834-index.htm", "trade_date": "2025-01-10", "timestamp": "2025-01-10", "mins": 952721}, {"id": "0000950170-24-135443", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Edward Miller", "who_key": "Miller Edward", "role": "General Counsel", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider files routine paperwork on ALVR \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024135443/0000950170-24-135443-index.htm", "trade_date": "2024-12-11", "timestamp": "2024-12-11", "mins": 995921}, {"id": "0000950170-24-129257", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Diana Brainard", "who_key": "Brainard Diana", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 4775.241, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO offloads $5K of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024129257/0000950170-24-129257-index.htm", "trade_date": "2024-11-19", "timestamp": "2024-11-19", "mins": 1027601}, {"id": "0000950170-24-129258", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Edward Miller", "who_key": "Miller Edward", "role": "General Counsel", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 236.952, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider offloads $236 of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024129258/0000950170-24-129258-index.htm", "trade_date": "2024-11-19", "timestamp": "2024-11-19", "mins": 1027601}, {"id": "0000950170-24-129259", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Vikas Sinha", "who_key": "Sinha Vikas", "role": "See Remarks, Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 1747.521, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Boardroom sells $2K of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024129259/0000950170-24-129259-index.htm", "trade_date": "2024-11-19", "timestamp": "2024-11-19", "mins": 1027601}, {"id": "0000950170-24-129263", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Brett R. Hagen", "who_key": "Hagen Brett R", "role": "Chief Accounting Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 303.86899999999997, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "An exit at the top? Exec sells $303 of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024129263/0000950170-24-129263-index.htm", "trade_date": "2024-11-19", "timestamp": "2024-11-19", "mins": 1027601}, {"id": "0000950170-24-122333", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Vikas Sinha", "who_key": "Sinha Vikas", "role": "See Remarks, Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 4442.1264, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Boardroom sells $4K of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024122333/0000950170-24-122333-index.htm", "trade_date": "2024-11-05", "timestamp": "2024-11-05", "mins": 1047761}, {"id": "0000950170-24-122334", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Brett R. Hagen", "who_key": "Hagen Brett R", "role": "Chief Accounting Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 1431.4095, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite trims ALVR: $1K", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024122334/0000950170-24-122334-index.htm", "trade_date": "2024-11-05", "timestamp": "2024-11-05", "mins": 1047761}, {"id": "0000950170-24-122335", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Edward Miller", "who_key": "Miller Edward", "role": "General Counsel", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 1965.0528, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider offloads $2K of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024122335/0000950170-24-122335-index.htm", "trade_date": "2024-11-05", "timestamp": "2024-11-05", "mins": 1047761}, {"id": "0000950170-24-122336", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Diana Brainard", "who_key": "Brainard Diana", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 9175.7241, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO sells $9K of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024122336/0000950170-24-122336-index.htm", "trade_date": "2024-11-05", "timestamp": "2024-11-05", "mins": 1047761}, {"id": "0000950170-24-116644", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Edward Miller", "who_key": "Miller Edward", "role": "General Counsel", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 1082.7998, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider trims $1K of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024116644/0000950170-24-116644-index.htm", "trade_date": "2024-10-22", "timestamp": "2024-10-22", "mins": 1067921}, {"id": "0000950170-24-116646", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Brett R. Hagen", "who_key": "Hagen Brett R", "role": "Chief Accounting Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 746.2918, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite trims ALVR: $746", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024116646/0000950170-24-116646-index.htm", "trade_date": "2024-10-22", "timestamp": "2024-10-22", "mins": 1067921}, {"id": "0000950170-24-116648", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Vikas Sinha", "who_key": "Sinha Vikas", "role": "See Remarks, Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 2649.3336, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Board member offloads $3K of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024116648/0000950170-24-116648-index.htm", "trade_date": "2024-10-22", "timestamp": "2024-10-22", "mins": 1067921}, {"id": "0000950170-24-116645", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Diana Brainard", "who_key": "Brainard Diana", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 7596.808, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO cashes out $8K of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024116645/0000950170-24-116645-index.htm", "trade_date": "2024-10-21", "timestamp": "2024-10-21", "mins": 1069361}, {"id": "0000950170-24-112911", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Brett R. Hagen", "who_key": "Hagen Brett R", "role": "Chief Accounting Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 245.2548, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite trims ALVR: $245", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024112911/0000950170-24-112911-index.htm", "trade_date": "2024-10-03", "timestamp": "2024-10-03", "mins": 1095281}, {"id": "0000950170-24-112912", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Diana Brainard", "who_key": "Brainard Diana", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 1216.4964, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO sells $1K of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024112912/0000950170-24-112912-index.htm", "trade_date": "2024-10-03", "timestamp": "2024-10-03", "mins": 1095281}, {"id": "0000950170-24-112913", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Edward Miller", "who_key": "Miller Edward", "role": "General Counsel", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 307.1796, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider sells $307 of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024112913/0000950170-24-112913-index.htm", "trade_date": "2024-10-03", "timestamp": "2024-10-03", "mins": 1095281}, {"id": "0000950170-24-112914", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Vikas Sinha", "who_key": "Sinha Vikas", "role": "See Remarks, Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 765.9119999999999, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Boardroom sells $765 of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024112914/0000950170-24-112914-index.htm", "trade_date": "2024-10-03", "timestamp": "2024-10-03", "mins": 1095281}, {"id": "0000950170-24-099846", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Diana Brainard", "who_key": "Brainard Diana", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 3995.607, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The corner office trims ALVR: $4K", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024099846/0000950170-24-099846-index.htm", "trade_date": "2024-08-20", "timestamp": "2024-08-20", "mins": 1158641}, {"id": "0000950170-24-099102", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Diana Brainard", "who_key": "Brainard Diana", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 2347.6144999999997, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO cashes out $2K of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024099102/0000950170-24-099102-index.htm", "trade_date": "2024-08-19", "timestamp": "2024-08-19", "mins": 1160081}, {"id": "0000950170-24-099103", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Vikas Sinha", "who_key": "Sinha Vikas", "role": "See Remarks, Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 2399.2605, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "A director trims ALVR: $2K", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024099103/0000950170-24-099103-index.htm", "trade_date": "2024-08-19", "timestamp": "2024-08-19", "mins": 1160081}, {"id": "0000950170-24-099104", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Brett R. Hagen", "who_key": "Hagen Brett R", "role": "Chief Accounting Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 413.16799999999995, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "An exit at the top? Exec sells $413 of ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000095017024099104/0000950170-24-099104-index.htm", "trade_date": "2024-08-19", "timestamp": "2024-08-19", "mins": 1160081}], "recent_buys": [{"id": "0001062993-23-014111", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Gilead Sciences, Inc.", "who_key": "GILEAD SCIENCES, INC.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 10990762.5, "score": 64.2, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "ALVR lands a $11M vote of confidence from A 10% owner", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000106299323014111/0001062993-23-014111-index.htm", "trade_date": "2023-06-27", "timestamp": "2023-06-27", "mins": 1763441}, {"id": "0000899243-22-015826", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Jeffrey S. Bornstein", "who_key": "Bornstein Jeffrey S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 23196.500000000004, "score": 33.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "ALVR lands a director's $23K", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322015826/0000899243-22-015826-index.htm", "trade_date": "2022-04-26", "timestamp": "2022-04-26", "mins": 2378321}, {"id": "0000899243-22-005623", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Jeffrey S. Bornstein", "who_key": "Bornstein Jeffrey S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 44349.99999999999, "score": 37.4, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "That makes 3 insiders into ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322005623/0000899243-22-005623-index.htm", "trade_date": "2022-02-10", "timestamp": "2022-02-10", "mins": 2486321}, {"id": "0000899243-20-021597", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Morana Jovan-Embiricos", "who_key": "Jovan-Embiricos Morana", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 49300000.0, "score": 77.4, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "That makes 3 insiders into ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924320021597/0000899243-20-021597-index.htm", "trade_date": "2020-08-03", "timestamp": "2020-08-03", "mins": 3286961}, {"id": "0000899243-20-021585", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Jeroen B. Van Beek", "who_key": "VAN BEEK JEROEN B", "role": "Chief Commercial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 51000.0, "score": 39.4, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "4 insiders pile into ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924320021585/0000899243-20-021585-index.htm", "trade_date": "2020-08-03", "timestamp": "2020-08-03", "mins": 3286961}, {"id": "0000899243-20-021577", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Diana Brainard", "who_key": "Brainard Diana", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 107100.0, "score": 39.4, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 5 buying ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924320021577/0000899243-20-021577-index.htm", "trade_date": "2020-08-03", "timestamp": "2020-08-03", "mins": 3286961}, {"id": "0000899243-20-021575", "src": "INSIDERS", "ticker": "ALVR", "cik": "1754068", "company": "Kalaris Therapeutics, Inc.", "company_raw": "Allovir, Inc.", "who": "Ercem Atillasoy", "who_key": "Atillasoy Ercem", "role": "See Remarks", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 59500.0, "score": 32.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "6 insiders now buying ALVR", "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924320021575/0000899243-20-021575-index.htm", "trade_date": "2020-08-03", "timestamp": "2020-08-03", "mins": 3286961}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Morana Jovan-Embiricos", "who_key": "Jovan-Embiricos Morana", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "bought": 49300000.0, "sold": 713823.0395, "net": 48586176.9605, "trades": 5, "top_score": 77.4, "lean": "buying", "history": [{"action": "SELL", "amount": 19812.0, "date": "2021-11-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321044619/0000899243-21-044619-index.htm"}, {"action": "SELL", "amount": 302455.1737, "date": "2021-11-09", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321043670/0000899243-21-043670-index.htm"}, {"action": "SELL", "amount": 54510.5, "date": "2021-10-27", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321042033/0000899243-21-042033-index.htm"}, {"action": "SELL", "amount": 337045.3658, "date": "2021-10-25", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321041467/0000899243-21-041467-index.htm"}, {"action": "BUY", "amount": 49300000.0, "date": "2020-08-03", "score": 77.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924320021597/0000899243-20-021597-index.htm"}], "latest": {"action": "SELL", "amount": 19812.0, "date": "2021-11-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321044619/0000899243-21-044619-index.htm"}}, {"who": "Gilead Sciences, Inc.", "who_key": "GILEAD SCIENCES, INC.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 10990762.5, "sold": 0, "net": 10990762.5, "trades": 1, "top_score": 64.2, "lean": "buying", "history": [{"action": "BUY", "amount": 10990762.5, "date": "2023-06-27", "score": 64.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000106299323014111/0001062993-23-014111-index.htm"}], "latest": {"action": "BUY", "amount": 10990762.5, "date": "2023-06-27", "score": 64.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000106299323014111/0001062993-23-014111-index.htm"}}, {"who": "David Hallal", "who_key": "Hallal David", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "bought": 0, "sold": 8928104.6014, "net": -8928104.6014, "trades": 7, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 5070000.0, "date": "2022-10-19", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322033994/0000899243-22-033994-index.htm"}, {"action": "SELL", "amount": 2940920.0, "date": "2022-09-29", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322032297/0000899243-22-032297-index.htm"}, {"action": "SELL", "amount": 22527.7965, "date": "2022-07-21", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322026519/0000899243-22-026519-index.htm"}, {"action": "SELL", "amount": 241105.59, "date": "2022-06-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322021183/0000899243-22-021183-index.htm"}, {"action": "SELL", "amount": 24812.49, "date": "2022-04-21", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322015395/0000899243-22-015395-index.htm"}, {"action": "SELL", "amount": 491849.8049, "date": "2022-03-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322010762/0000899243-22-010762-index.htm"}, {"action": "SELL", "amount": 136888.92, "date": "2022-01-24", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322003144/0000899243-22-003144-index.htm"}], "latest": {"action": "SELL", "amount": 5070000.0, "date": "2022-10-19", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322033994/0000899243-22-033994-index.htm"}}, {"who": "Malcolm Brenner", "who_key": "Brenner Malcolm", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 0, "sold": 7340203.3695, "net": -7340203.3695, "trades": 5, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 3272798.112, "date": "2021-03-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000120919121018532/0001209191-21-018532-index.htm"}, {"action": "SELL", "amount": 2000565.3482, "date": "2021-03-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000120919121017524/0001209191-21-017524-index.htm"}, {"action": "SELL", "amount": 1322217.1915000002, "date": "2021-02-23", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000120919121013481/0001209191-21-013481-index.htm"}, {"action": "SELL", "amount": 275365.77280000004, "date": "2021-02-18", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321007328/0000899243-21-007328-index.htm"}, {"action": "SELL", "amount": 469256.945, "date": "2021-02-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321007278/0000899243-21-007278-index.htm"}], "latest": {"action": "SELL", "amount": 3272798.112, "date": "2021-03-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000120919121018532/0001209191-21-018532-index.htm"}}, {"who": "John Robert Wilson", "who_key": "Wilson John Robert", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 0, "sold": 6268101.334925001, "net": -6268101.334925001, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 6268101.334925001, "date": "2021-03-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321011155/0000899243-21-011155-index.htm"}], "latest": {"action": "SELL", "amount": 6268101.334925001, "date": "2021-03-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321011155/0000899243-21-011155-index.htm"}}, {"who": "Jeroen B. Van Beek", "who_key": "VAN BEEK JEROEN B", "role": "Chief Commercial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 51000.0, "sold": 6019531.736, "net": -5968531.736, "trades": 24, "top_score": 39.4, "lean": "selling", "history": [{"action": "SELL", "amount": 120527.67420000001, "date": "2022-11-16", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322036362/0000899243-22-036362-index.htm"}, {"action": "SELL", "amount": 299904.3728, "date": "2022-11-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322035893/0000899243-22-035893-index.htm"}, {"action": "SELL", "amount": 107292.8398, "date": "2022-11-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322035551/0000899243-22-035551-index.htm"}, {"action": "SELL", "amount": 10015.948999999999, "date": "2022-10-20", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322034262/0000899243-22-034262-index.htm"}, {"action": "SELL", "amount": 10015.948999999999, "date": "2022-10-19", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322034059/0000899243-22-034059-index.htm"}, {"action": "SELL", "amount": 3889.1784, "date": "2022-09-02", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322030423/0000899243-22-030423-index.htm"}, {"action": "SELL", "amount": 129473.391, "date": "2022-08-16", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322029045/0000899243-22-029045-index.htm"}, {"action": "SELL", "amount": 5516.941, "date": "2022-07-20", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322026516/0000899243-22-026516-index.htm"}, {"action": "SELL", "amount": 1870.5315, "date": "2022-06-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322025233/0000899243-22-025233-index.htm"}, {"action": "SELL", "amount": 67166.5358, "date": "2022-05-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322018526/0000899243-22-018526-index.htm"}, {"action": "SELL", "amount": 5695.0236, "date": "2022-04-20", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322015393/0000899243-22-015393-index.htm"}, {"action": "SELL", "amount": 4651.3788, "date": "2022-03-02", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322009059/0000899243-22-009059-index.htm"}, {"action": "SELL", "amount": 127525.00600000001, "date": "2022-02-16", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322007029/0000899243-22-007029-index.htm"}, {"action": "SELL", "amount": 40752.105599999995, "date": "2022-01-20", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322003004/0000899243-22-003004-index.htm"}, {"action": "SELL", "amount": 8770.2278, "date": "2021-12-02", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321046758/0000899243-21-046758-index.htm"}, {"action": "SELL", "amount": 321262.1945, "date": "2021-11-16", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321045272/0000899243-21-045272-index.htm"}, {"action": "SELL", "amount": 416905.7005, "date": "2021-10-01", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321038676/0000899243-21-038676-index.htm"}, {"action": "SELL", "amount": 1409645.6395999999, "date": "2021-09-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321036636/0000899243-21-036636-index.htm"}, {"action": "SELL", "amount": 230033.50040000002, "date": "2021-03-01", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000120919121017534/0001209191-21-017534-index.htm"}, {"action": "SELL", "amount": 376620.9502, "date": "2021-02-23", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000120919121013485/0001209191-21-013485-index.htm"}, {"action": "SELL", "amount": 84786.7865, "date": "2021-02-18", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321007332/0000899243-21-007332-index.htm"}, {"action": "SELL", "amount": 222606.96, "date": "2021-02-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321007272/0000899243-21-007272-index.htm"}, {"action": "SELL", "amount": 2014602.9, "date": "2021-02-02", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321004952/0000899243-21-004952-index.htm"}, {"action": "BUY", "amount": 51000.0, "date": "2020-08-03", "score": 39.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924320021585/0000899243-20-021585-index.htm"}], "latest": {"action": "SELL", "amount": 120527.67420000001, "date": "2022-11-16", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924322036362/0000899243-22-036362-index.htm"}}, {"who": "Ann M. Leen", "who_key": "Leen Ann M.", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 0, "sold": 5391158.7523, "net": -5391158.7523, "trades": 7, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 465559.20120000007, "date": "2021-11-16", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321044889/0000899243-21-044889-index.htm"}, {"action": "SELL", "amount": 3412500.0, "date": "2021-05-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000120919121031337/0001209191-21-031337-index.htm"}, {"action": "SELL", "amount": 90750.9075, "date": "2021-03-16", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000120919121021808/0001209191-21-021808-index.htm"}, {"action": "SELL", "amount": 368329.2071, "date": "2021-03-01", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000120919121017527/0001209191-21-017527-index.htm"}, {"action": "SELL", "amount": 723624.5799, "date": "2021-02-23", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000120919121013484/0001209191-21-013484-index.htm"}, {"action": "SELL", "amount": 110194.24, "date": "2021-02-18", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321007336/0000899243-21-007336-index.htm"}, {"action": "SELL", "amount": 220200.6166, "date": "2021-02-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321007275/0000899243-21-007275-index.htm"}], "latest": {"action": "SELL", "amount": 465559.20120000007, "date": "2021-11-16", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321044889/0000899243-21-044889-index.htm"}}, {"who": "Juan Vera", "who_key": "Vera Juan", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 0, "sold": 5063732.6359, "net": -5063732.6359, "trades": 4, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 2451759.6661, "date": "2021-03-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000120919121017536/0001209191-21-017536-index.htm"}, {"action": "SELL", "amount": 1511309.6587999999, "date": "2021-02-23", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000120919121013486/0001209191-21-013486-index.htm"}, {"action": "SELL", "amount": 364368.35860000004, "date": "2021-02-18", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321007331/0000899243-21-007331-index.htm"}, {"action": "SELL", "amount": 736294.9524000001, "date": "2021-02-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000089924321007279/0000899243-21-007279-index.htm"}], "latest": {"action": "SELL", "amount": 2451759.6661, "date": "2021-03-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1754068/000120919121017536/0001209191-21-017536-index.htm"}}], "activity": [], "announcements": [{"form": "4", "date": "2026-08-28", "title": "Insider transaction", "accession": "0001193125-26-374352", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-11", "title": "Quarterly report", "accession": "0001193125-26-344532", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-11", "title": "Material event", "accession": "0001193125-26-343477", "price_sensitive": true}, {"form": "4", "date": "2026-08-03", "title": "Insider transaction", "accession": "0001193125-26-330530", "price_sensitive": false}, {"form": "3", "date": "2026-08-03", "title": "Initial insider holdings", "accession": "0001193125-26-330516", "price_sensitive": false}, {"form": "3", "date": "2026-07-27", "title": "Initial insider holdings", "accession": "0001193125-26-318054", "price_sensitive": false}, {"form": "4", "date": "2026-07-20", "title": "Insider transaction", "accession": "0001193125-26-309047", "price_sensitive": false}, {"form": "3", "date": "2026-07-20", "title": "Initial insider holdings", "accession": "0001193125-26-309027", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-20", "title": "Material event", "accession": "0001193125-26-308382", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-17", "title": "Material event", "accession": "0001193125-26-306737", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-06", "title": "Material event", "accession": "0001193125-26-296190", "price_sensitive": true}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257564", "price_sensitive": false}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257556", "price_sensitive": false}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257494", "price_sensitive": false}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257471", "price_sensitive": false}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257465", "price_sensitive": false}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257462", "price_sensitive": false}, {"form": "4", "date": "2026-06-04", "title": "Insider transaction", "accession": "0001193125-26-257445", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-04", "title": "Material event", "accession": "0001193125-26-257388", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2026-05-22", "title": "Form SCHEDULE 13D/A", "accession": "0001699737-26-000012", "price_sensitive": false}, {"form": "4", "date": "2026-05-22", "title": "Insider transaction", "accession": "0001231919-26-000532", "price_sensitive": false}, {"form": "10-Q", "date": "2026-05-12", "title": "Quarterly report", "accession": "0001193125-26-219328", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-12", "title": "Material event", "accession": "0001193125-26-218240", "price_sensitive": true}, {"form": "ARS", "date": "2026-04-24", "title": "Form ARS", "accession": "0001193125-26-177387", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-04-24", "title": "Form DEFA14A", "accession": "0001193125-26-177383", "price_sensitive": false}], "performance": {"ticker": "ALVR", "has_prices": false, "summary": null, "buys": [{"who": "GILEAD SCIENCES, INC.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 10990762.5, "date": "2023-06-27", "score": 64.2, "ref_price": null, "return": null}, {"who": "Bornstein Jeffrey S", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 23196.500000000004, "date": "2022-04-26", "score": 33.7, "ref_price": null, "return": null}, {"who": "Bornstein Jeffrey S", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 44349.99999999999, "date": "2022-02-10", "score": 37.4, "ref_price": null, "return": null}, {"who": "Jovan-Embiricos Morana", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 49300000.0, "date": "2020-08-03", "score": 77.4, "ref_price": null, "return": null}, {"who": "VAN BEEK JEROEN B", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Commercial Officer", "amount": 51000.0, "date": "2020-08-03", "score": 39.4, "ref_price": null, "return": null}, {"who": "Brainard Diana", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 107100.0, "date": "2020-08-03", "score": 39.4, "ref_price": null, "return": null}, {"who": "Atillasoy Ercem", "person_type": "EXEC", "person_label": "Execs", "role": "See Remarks", "amount": 59500.0, "date": "2020-08-03", "score": 32.1, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}